JDD February 2023 Issue Highlights
The February issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and brief communications exploring topics such as efficacy and safety of 1% clascoterone cream in patients aged ≥12 years with acne vulgaris, dupilumab’s impact on atopic dermatitis among adolescent and adult patients, development and validation of a photonumeric scale …
The February issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and brief communications exploring topics such as efficacy and safety of 1% clascoterone cream in patients aged ≥12 years with acne vulgaris, dupilumab’s impact on atopic dermatitis among adolescent and adult patients, development and validation of a photonumeric scale … 
Next Steps in Derm and the Journal of Drugs in Dermatology, in partnership with the Dermatology Education Foundation (DEF) and Physicians Resources, interviewed Dr. Adam Friedman, professor and chair of dermatology at GW School of Medicine and Health Sciences, on life lessons from his residency and career. Dr. Friedman provides his tips for remaining calm during the craziest of office visits. … 
A study on the safety of UV lights during gel manicures is the most popular dermatology topic in the consumer press this month. Dermatologists have long been concerned that routine gel manicures with UV lights would be associated with a higher risk of skin cancer. A study in Nature Communications demonstrates that the radiation emitted by these UV nail polish dryers does damage DNA and cause perma … 
INTRODUCTION
Epoprostenol (Flolan) is a last-resort intravenous (IV) medication for the treatment of severe pulmonary arterial hypertension (PAH). Cutaneous adverse events of Flolan are well-known by pulmonologists, though lacking in dermatologic literature.1 We report an extensive near erythrodermic appearing asymptomatic eruption following long-term use of epoprostenol. This characteristic and … 
Patients with darker skin types are susceptible to developing other pigmentary disorders besides melasma. At SOCU 2022, Dr. Heather Woolery-Lloyd, Director of the Skin of Color Division at the University of Miami Miller School of Medicine, gave a fascinating overview of various pigmentary disorders that can affect patients with skin of color and provided clinical pearls immediately useful in our p … 